Page last updated: 2024-08-21

diphenylamine and Orthopedic Disorders

diphenylamine has been researched along with Orthopedic Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Adrian, DE; Forster, S; Friton, G; King, JN; Lascelles, BDX; Seewald, W1
Boasberg, PD; Bodkin, D; Daniels, GA; Garrett, CR; Redfern, CH; Ricart, AD1
King, JN; Okumura, M; Sakakibara, N; Sano, T; Seewald, W1

Trials

2 trial(s) available for diphenylamine and Orthopedic Disorders

ArticleYear
Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Breast Neoplasms; Cohort Studies; Colonic Neoplasms; Diphenylamine; Early Termination of Clinical Trials; Extracellular Signal-Regulated MAP Kinases; Eye Diseases; Female; Humans; Male; Melanoma; Middle Aged; Musculoskeletal Diseases; Neoplasm Staging; Neurotoxicity Syndromes; Pilot Projects

2011
Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial.
    Veterinary journal (London, England : 1997), 2012, Volume: 193, Issue:2

    Topics: Acute Pain; Administration, Oral; Animals; Cat Diseases; Cats; Cyclooxygenase 2 Inhibitors; Diphenylamine; Female; Inflammation; Ketoprofen; Male; Musculoskeletal Diseases; Phenylacetates; Prospective Studies; Single-Blind Method; Tablets

2012

Other Studies

1 other study(ies) available for diphenylamine and Orthopedic Disorders

ArticleYear
Clinical safety of robenacoxib in cats with chronic musculoskeletal disease.
    Journal of veterinary internal medicine, 2021, Volume: 35, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Diphenylamine; Musculoskeletal Diseases; Phenylacetates; Prospective Studies

2021